title: Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination.
abstract: Topoisomerase II (Top2) is a nuclear enzyme involved in several metabolic processes of DNA. Chemotherapy agents that poison Top2 are known to induce persistent protein-mediated DNA double strand breaks (DSB). In this report, by using knock down experiments, we demonstrated that Top2alpha was largely responsible for the induction of gammaH2AX and cytotoxicity by the Top2 poisons idarubicin and etoposide in normal human cells. As DSB resulting from Top2 poisons-mediated damage may be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR), we aimed to analyze both DNA repair pathways. We found that DNA-PKcs was rapidly activated in human cells, as evidenced by autophosphorylation at serine 2056, following Top2-mediated DNA damage. The chemical inhibition of DNA-PKcs by wortmannin and vanillin resulted in an increased accumulation of DNA DSB, as evaluated by the comet assay. This was supported by a hypersensitive phenotype to Top2 poisons of Ku80- and DNA-PKcs- defective Chinese hamster cell lines. We also showed that Rad51 protein levels, Rad51 foci formation and sister chromatid exchanges were increased in human cells following Top2-mediated DNA damage. In support, BRCA2- and Rad51C- defective Chinese hamster cells displayed hypersensitivity to Top2 poisons. The analysis by immunofluorescence of the DNA DSB repair response in synchronized human cell cultures revealed activation of DNA-PKcs throughout the cell cycle and Rad51 foci formation in S and late S/G2 cells. Additionally, we found an increase of DNA-PKcs-mediated residual repair events, but not Rad51 residual foci, into micronucleated and apoptotic cells. Therefore, we conclude that in human cells both NHEJ and HR are required, with cell cycle stage specificity, for the repair of Top2-mediated reversible DNA damage. Moreover, NHEJ-mediated residual repair events are more frequently associated to irreversibly damaged cells.
authors.affiliation: Departamento de Genética, Instituto de Investigaciones Hematológicas Mariano R. Castex, Academia Nacional de Medicina, Buenos Aires, Argentina. mnebel@hematologia.anm.edu.ar
authors.forename: Marcelo
authors.initials: M
authors.lastname: de Campos-Nebel
authors.forename: Irene
authors.initials: I
authors.lastname: Larripa
authors.forename: Marcela
authors.initials: M
authors.lastname: González-Cid
mesh_terms: D000818:Animals; D002453:Cell Cycle; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D053903:DNA Breaks, Double-Stranded; D004249:DNA Damage; D004260:DNA Repair; D004250:DNA Topoisomerases, Type II / Q000235:genetics / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D011995:Recombination, Genetic
chemical_list: D004268:DNA-Binding Proteins; C448305:RAD51C protein, human; D004250:DNA Topoisomerases, Type II
references.citation: J Biol Chem. 2008 Jan 4;283(1):1-5
references.pmid: 17999957
references.citation: Mol Cell Biol. 2006 Nov;26(21):7929-41
references.pmid: 16923961
references.citation: Cancer Res. 2001 Jun 1;61(11):4550-5
references.pmid: 11389089
references.citation: J Biol Chem. 2008 Aug 29;283(35):23711-20
references.pmid: 18596031
references.citation: DNA Cell Biol. 2005 Jun;24(6):388-93
references.pmid: 15941391
references.citation: EMBO J. 1998 Sep 15;17(18):5497-508
references.pmid: 9736627
references.citation: BMC Pharmacol. 2004 Dec 02;4:31
references.pmid: 15575955
references.citation: Mol Cell Biol. 2005 Dec;25(24):10842-52
references.pmid: 16314509
references.citation: DNA Repair (Amst). 2008 Mar 1;7(3):452-63
references.pmid: 18206427
references.citation: Mol Cancer Ther. 2006 Jun;5(6):1405-14
references.pmid: 16818498
references.citation: DNA Repair (Amst). 2006 May 10;5(5):575-90
references.pmid: 16567133
references.citation: J Biol Chem. 2001 Nov 2;276(44):40652-8
references.pmid: 11546768
references.citation: Bioessays. 1998 Mar;20(3):215-26
references.pmid: 9631649
references.citation: Mol Cell Biol. 2003 Aug;23(16):5706-15
references.pmid: 12897142
references.citation: Cell. 2006 Jan 27;124(2):287-99
references.pmid: 16439204
references.citation: Electrophoresis. 1999 Jul;20(10):2133-8
references.pmid: 10451126
references.citation: DNA Repair (Amst). 2006 Sep 8;5(9-10):1075-81
references.pmid: 16798112
references.citation: Am J Hum Genet. 1997 Oct;61(4):795-800
references.pmid: 9382087
references.citation: Cell Cycle. 2008 Sep 15;7(18):2902-6
references.pmid: 18769152
references.citation: J Cell Biol. 2007 Apr 23;177(2):219-29
references.pmid: 17438073
references.citation: DNA Repair (Amst). 2006 Sep 8;5(9-10):1093-108
references.pmid: 16857431
references.citation: Biochem Biophys Res Commun. 2004 Jun 11;318(4):856-61
references.pmid: 15147950
references.citation: DNA Repair (Amst). 2007 Jul 1;6(7):923-35
references.pmid: 17363343
references.citation: Nat Genet. 2001 Mar;27(3):247-54
references.pmid: 11242102
references.citation: J Cell Sci. 2004 Mar 1;117(Pt 7):1047-54
references.pmid: 14996935
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Cancer Lett. 2003 Apr 10;193(1):1-9
references.pmid: 12691817
references.citation: Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40
references.pmid: 12042765
references.citation: J Biol Chem. 1998 Dec 11;273(50):33660-6
references.pmid: 9837951
references.citation: Cell. 1988 Oct 7;55(1):7-16
references.pmid: 3167977
references.citation: Mol Cell Biol. 1997 Oct;17(10):6087-96
references.pmid: 9315668
references.citation: Mol Cell Biol. 1999 Jul;19(7):5166-9
references.pmid: 10373565
references.citation: Nucleic Acids Res. 2009 Feb;37(3):738-48
references.pmid: 19042970
references.citation: Cell. 1992 Sep 18;70(6):983-91
references.pmid: 1356077
references.citation: Bioessays. 1997 Feb;19(2):97-9
references.pmid: 9046238
references.citation: J Biol Chem. 1994 Jan 14;269(2):1173-6
references.pmid: 8288578
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9053-8
references.pmid: 18574145
references.citation: Clin Chim Acta. 2007 Apr;379(1-2):1-13
references.pmid: 17306783
references.citation: Cancer Res. 2007 Aug 1;67(15):7078-81
references.pmid: 17671173
references.citation: J Biol Chem. 2003 Sep 19;278(38):35897-902
references.pmid: 12842886
references.citation: J Cell Biol. 1999 Jan 11;144(1):11-20
references.pmid: 9885240
references.citation: J Mol Biol. 2003 Feb 7;326(1):93-103
references.pmid: 12547193
references.citation: Cancer Res. 1990 Sep 15;50(18):5778-83
references.pmid: 2168280
references.citation: Apoptosis. 2010 Feb;15(2):162-72
references.pmid: 20041303
references.citation: J Biol Chem. 1996 Nov 15;271(46):29238-44
references.pmid: 8910583
references.citation: Genes Dev. 2001 Dec 15;15(24):3308-18
references.pmid: 11751636
references.citation: Annu Rev Biochem. 1996;65:635-92
references.pmid: 8811192
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11014-9
references.pmid: 17578914
references.citation: Cytometry A. 2004 Apr;58(2):99-110
references.pmid: 15057963
references.citation: J Cell Sci. 2002 Jan 1;115(Pt 1):153-64
references.pmid: 11801733
references.citation: J Biol Chem. 2005 Apr 15;280(15):14709-15
references.pmid: 15677476
references.citation: Cancer Res. 2003 Mar 15;63(6):1377-81
references.pmid: 12649202
references.citation: Br J Cancer. 1997;75(9):1340-6
references.pmid: 9155056
references.citation: Cell. 2006 Jan 27;124(2):301-13
references.pmid: 16439205
references.citation: Nucleic Acids Res. 1994 Jun 25;22(12):2274-81
references.pmid: 8036155
references.citation: Genes Dev. 2002 Sep 15;16(18):2333-8
references.pmid: 12231622
references.citation: Science. 2006 Jun 23;312(5781):1798-802
references.pmid: 16794079